Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

S. Peters; J.-L. Pujol; U. Dafni; M. Dómine; S. Popat; M. Reck; J. Andrade; A. Becker; D. Moro-Sibilot; A. Curioni-Fontecedro; O. Molinier; K. Nackaerts; A. Insa Mollá; R. Gervais; G. López Vivanco; J. Madelaine; J. Mazieres; M. Faehling; F. Griesinger; M. Majem; J.L. González Larriba; M. Provencio Pulla; K. Vervita; H. Roschitzki-Voser; B. Ruepp; P. Mitchell; R.A. Stahel; C. Le Pechoux; D. de Ruysscher; R. Stahel; A. Hiltbrunner; M. Pardo-Contreras; A. Gasca-Ruchti; N. Giacomelli; R. Kammler; N. Marti; R. Pfister; A.C. Piguet; S. Roux; S. Troesch; M. Schneider; R. Schweri; I. Zigomo; Z. Tsourti; P. Zygoura; S. Tsouprou; M. Kassapian; G. Dimopoulou; C. Andriakopoulou; F. Morin; E. Amour; G. Mariaule; N. Archirel; M. Fernandez; E. Pereira; L. Benito; K. Lopez; A. Hernández; S. Chinchen; H. Jurkovic; A. Livingstone; J. Mitchell; M. Walker; S. Ng; C. Steer; K. Briscoe; A. Saqib; E. Abdi; B. Houghton; K. O’byrne; B.R. Chittajallu; B.G. Hughes; A. Black; H. Werner; G. Zalcman; F. Vaylet; P. Merle; I. Monnet; N. Girard; P.-J. Souquet; F. Barlesi; D. Debieuvre; H. Senellart; M. Poudenx; A. Dixmier; D. Pouessel; J. Cadranel; H. Lena; E. Quoix; S. Friard; C. Audigier-Valette; E. Pichon; K. Kokowski; H. Kirchen; A. Tufman; C. De-Colle; J. de Langen; A. Insa; B. Massutí; M.P. Pulla; S.P. Aix; N. Villanueva; G.L. Vivanco; K. Franks; R. Califano

doi:10.1016/j.annonc.2021.09.011

Retour

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

Article de revue

Open Access

Avec comité de lecture

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

S. Peters, J.-L. Pujol, U. Dafni, M. Dómine, S. Popat, M. Reck, J. Andrade, A. Becker, D. Moro-Sibilot, A. Curioni-Fontecedro, …

Annals of Oncology, Vol.33(1), pp.67-79

01/2022

DOI: https://doi.org/10.1016/j.annonc.2021.09.011

Fichiers et liens (2)

url

Find in HALAfficher

url

https://doi.org/10.1016/j.annonc.2021.09.011Afficher

Published (Version of record) Ouvrir

Indicateurs

1 Consultations de la notice

See more details

Détails

Titre: Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial
Créateurs - sans rôle: S. Peters - University Hospital of Lausanne
J.-L. Pujol - Hôpital Arnaud de Villeneuve
U. Dafni - Frontier Science Foundation-Hellas
M. Dómine - Hospital Universitario Fundación Jiménez Díaz
S. Popat - Royal Marsden Hospital
M. Reck - German Center for Lung Research
J. Andrade - Hospital Virgen de la Salud
A. Becker - Israel Trauma Group
D. Moro-Sibilot - Centre Hospitalier Universitaire de Grenoble
A. Curioni-Fontecedro - University Hospital of Zurich
O. Molinier - Centre Hospitalier du Mans
K. Nackaerts - KU Leuven
A. Insa Mollá
R. Gervais - Centre François Baclesse
G. López Vivanco
J. Madelaine - Centre Hospitalier Universitaire de Caen Normandie
J. Mazieres - Centre Hospitalier Universitaire de Toulouse
M. Faehling - Klinikum Esslingen
F. Griesinger - Pius Hospital Oldenburg
M. Majem - Hospital de Sant Pau
J.L. González Larriba
M. Provencio Pulla
K. Vervita - Frontier Science Foundation-Hellas
H. Roschitzki-Voser
B. Ruepp
P. Mitchell - Olivia Newton-John Cancer Wellness & Research Centre
R.A. Stahel
C. Le Pechoux - Institut Gustave Roussy
D. de Ruysscher - Maastricht University
R. Stahel
A. Hiltbrunner
M. Pardo-Contreras
A. Gasca-Ruchti
N. Giacomelli - Hospital Universitario Puerta de Hierro Majadahonda
R. Kammler
N. Marti - Hospital Universitario Puerta de Hierro Majadahonda
R. Pfister
A.C. Piguet - KU Leuven
S. Roux
S. Troesch
M. Schneider
R. Schweri
I. Zigomo
Z. Tsourti
P. Zygoura
S. Tsouprou
M. Kassapian
K. Vervita - Frontier Science Foundation-Hellas
G. Dimopoulou - Hospital Clínico San Carlos
C. Andriakopoulou
F. Morin
E. Amour
G. Mariaule - Hospital Clínico San Carlos
N. Archirel - Hospital Universitario Puerta de Hierro Majadahonda
M. Fernandez
E. Pereira
L. Benito
K. Lopez - Hospital de Cruces
A. Hernández
S. Chinchen
H. Jurkovic - Maastro Clinic
A. Livingstone
J. Mitchell - Austin Hospital
M. Walker
P. Mitchell - Olivia Newton-John Cancer Wellness & Research Centre
S. Ng - Pius Hospital Oldenburg
C. Steer
K. Briscoe
A. Saqib
E. Abdi
B. Houghton
K. O’byrne
B.R. Chittajallu
B.G. Hughes
A. Black
K. Nackaerts - KU Leuven
H. Werner
R. Gervais - Centre François Baclesse
G. Zalcman - Hospital Clínico San Carlos
F. Vaylet
P. Merle
I. Monnet
D. Moro-Sibilot - Centre Hospitalier Universitaire de Grenoble
O. Molinier - Centre Hospitalier du Mans
N. Girard - Hospital Universitario Puerta de Hierro Majadahonda
P.-J. Souquet
F. Barlesi
D. Debieuvre - Maastro Clinic
H. Senellart - Maastro Clinic
M. Poudenx
A. Dixmier
D. Pouessel - Maastro Clinic
J. Cadranel - Hospital Clínico San Carlos
H. Lena - Maastricht University
E. Quoix
S. Friard
C. Audigier-Valette
J. Mazieres - Centre Hospitalier Universitaire de Toulouse
E. Pichon
M. Faehling - Klinikum Esslingen
K. Kokowski
H. Kirchen
F. Griesinger - Pius Hospital Oldenburg
A. Tufman
C. De-Colle
J. de Langen
J.L. González Larriba
A. Insa
M. Majem - Hospital de Sant Pau
B. Massutí
M.P. Pulla
S.P. Aix
N. Villanueva
G.L. Vivanco
J. Andrade - Hospital Virgen de la Salud
A. Curioni-Fontecedro - University Hospital of Zurich
K. Franks
R. Califano
Détails de publication: Annals of Oncology, Vol.33(1), pp.67-79
Identifiants: 99152801309311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM
Langue: English
Type de ressource: Journal article
Champs locaux: hal-05036192